APLF Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-84442
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the C-terminal region of Human APLF. Peptide sequence: NVLDEDNDNVGQPNEYDLNDSFLDDEEEDYEPTDEDSDWEPGKEDEEKED The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for APLF Antibody
![Western Blot: APLF Antibody [NBP2-84442]](https://resources.bio-techne.com/images/products/APLF-Antibody-Western-Blot-NBP2-84442-img0001.jpg "Western Blot: APLF Antibody [NBP2-84442]")
Western Blot: APLF Antibody [NBP2-84442]
Western Blot: APLF Antibody [NBP2-84442] - WB Suggested Anti-APLF Antibody. Titration: 1.0 ug/ml. Positive Control: PANC1 Whole CellApplications for APLF Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: APLF
Alternate Names
APFL, aprataxin- and PNK-like factor, aprataxin and PNK-like factor, aprataxin and PNKP like factor, Apurinic-apyrimidinic endonuclease APLF, C2orf13FLJ16593, chromosome 2 open reading frame 13, EC 4.2.99.18, MGC47799, PALF, PNK and APTX-like FHA domain-containing protein, PNK and APTX-like FHA protein, XIP1, XRCC1-interacting protein 1
Gene Symbol
APLF
Additional APLF Products
Product Specific Notices for APLF Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...